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ABSTRACT
CONTEXT AND OBJECTIVE: Serological testing for CA125 has been widely used to detect endometriosis and to monitor its progression. However, controversy 
still exists regarding the usefulness of the plasma CA125 assay for diagnosing endometriosis. Furthermore, some authors have described superficial 
endometriosis as a cyclical and normal phenomenon in women’s lives, and have indicated that development and progression of this disease would only 
occur in some women as a result of immunological changes. This study aimed to determine the frequency of endometriosis and the correlation between 
serum CA125 levels and the presence of endometriotic lesions in the peritoneum of asymptomatic fertile patients. 
DESIGN AND SETTING: Cross-sectional study at the Family Planning outpatient clinic of Faculdade de Medicina do ABC. 
METHODS: Eighty asymptomatic fertile patients who underwent tubal sterilization surgery were studied. Blood and peritoneum samples were collected. 
CA125 levels were measured from blood samples, and peritoneum biopsies were studied using histopathological tests. 
RESULTS: Histopathological evaluation of the peritoneum revealed that 16.25% of the patients had minimal or mild endometriosis. There was no 
statistically significant difference in CA125 levels between patients with and without endometriosis. 
CONCLUSION: The presence of endometriotic lesions in the peritoneum of fertile patients supports the hypothesis that incidental findings of minimal or 
mild endometriosis may not be of clinical significance, and that the progression of the disease probably occurs as a result of immunological and genetic 
abnormalities. Serum CA125 levels did not show any diagnostic significance with regard to detecting the disease. 
RESUMO
CONTEXTO E OBJETIVO: O teste sorológico para CA125 tem sido largamente usado para detectar e monitorar a progressão da endometriose, entretanto, a 
utilidade do ensaio do CA125 plasmático para o diagnóstico da endometriose ainda é controversa. Além disso, alguns autores descreveram a endometriose 
superficial como sendo um fenômeno cíclico e normal na vida de uma mulher, e que o desenvolvimento e progressão desta doença ocorreriam apenas 
em algumas mulheres como resultado de alterações imunológicas. Este estudo teve como objetivo determinar a freqüência de endometriose e a 
correlação entre os níveis séricos de CA125 e a presença de lesões endometrióticas em peritônio de pacientes férteis assintomáticas. 
TIPO DE ESTUDO E LOCAL: Estudo transversal realizado no Ambulatório de Planejamento Familiar da Faculdade de Medicina do ABC. 
MÉTODOS: Foram estudadas 80 pacientes férteis assintomáticas submetidas à cirurgia de esterilização tubária. Amostras de sangue e peritônio foram 
coletadas. Os níveis de CA125 foram medidos a partir das amostras de sangue e as biópsias de peritônio foram estudadas por ensaio histopatológico. 
RESULTADOS: O estudo histopatológico do peritônio revelou que 16,25% das pacientes apresentavam endometriose mínima e leve. Os níveis de CA125 
não demonstraram diferença estatística significante entre pacientes com e sem endometriose. 
CONCLUSÃO: A presença de lesões endometrióticas em peritônio de pacientes férteis reforça a hipótese de que achados acidentais de endometriose 
mínima e leve podem não ter significância clínica, e que é provável que a progressão da doença ocorra como resultado de alterações genéticas e 
imunológicas. Os níveis séricos de CA125 não demonstraram significância diagnóstica para a detecção da doença. 
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INTRODUCTION
An endometriotic lesion is defined as the presence of endometrial 
tissue outside the uterus, thus causing infertility, pelvic pain and dys-
menorrhea.1 Estimates of the frequency of endometriosis range from 
10-15% in women of reproductive age2 up to 50% in women with fer-
tility problems1 and around 60%-70% in women with chronic pelvic 
pain.3 However, up to 20% of women may have endometriosis without 
presenting any symptoms.1 
In clinical practice, severe endometriosis can be diagnosed with 
high accuracy by means of pelvic examination and through using im-
aging tools such as transvaginal ultrasonography4 and magnetic reso-
nance.5 However, these methods are not sensitive enough to detect mild 
endometriosis,6 and laparoscopy or laparotomy is necessary in order to 
confirm the diagnosis and classify the stage of endometriosis according 
to the criteria of the American Fertility Society.7
Some authors have described superficial endometriosis as a cycli-
cal and normal phenomenon in women’s lives, and have indicated that 
development and progression of this disease would only occur in some 
women as a result of immunological changes.8,9 Thus, the low specific-
ity of the diagnostic methods available, along with the severity of the 
disease, has motivated new studies to search for noninvasive diagnostic 
methods to detection endometriosis.6
Serological testing for CA125 has been widely used to detect endo-
metriosis and to monitor its progression.10 However, controversy still 
exists regarding the usefulness of the plasma CA125 assay for diagnos-
ing endometriosis.11,12 Moreover, only a small and limited number of 
studies in the literature have combined peritoneal and serum samples,3 
especially among asymptomatic fertile women.
OBJECTIVE
This study aimed to determine the frequency of endometriosis and 
the correlation between serum CA125 levels and the presence of endo-
metriotic lesions in the peritoneum of asymptomatic fertile patients.
MATERIAl AND METhODS
Patients
Eighty fertile women with no symptoms of endometriosis such as 
infertility, pelvic pain and/or dysmenorrhea (aged 21-44 years, mean: 
33.68 ± 4.63) were studied. All of the subjects were attending the 
Family Planning outpatient clinic of Faculdade de Medicina do ABC 
(FMABC), Santo André, Brazil, and underwent surgery for tubal steril-
ization as a familiar planning measure. 
The study protocol was approved by the local research ethics commit-
tee. All patients gave their informed consent for inclusion in the study. 
METhODS
histopathological evaluation
The patients underwent laparoscopic surgery for tubal sterilization 
and, during the procedure, small pieces of peritoneum were excised 
from four different sites: left and right ovarian fossae, and left and right 
sacrouterine ligaments. 
The biopsy specimens were fixed in a 10% formalin solution and 
embedded in paraffin. Histological sections (3-5 mm thick) were cut 
and stained with hematoxylin-eosin. A total of 320 microscope slides 
stained with hematoxylin-eosin were studied (Figure 1). 
The criterion for histological classification of endometriosis was 
identification of stromal endometrioid or epithelial elements of Mülle-
rian type, with or without stroma, associated with signs of hemorrhage 
and fibrosis.
After histological confirmation of the diagnosis of endometriosis, 
the lesions were classified morphologically, based on the variations in 
appearance of the ectopic endometrial structures.13 The morphologi-
cal criteria for the analysis were: stromal disease, when only endome-
trial stroma was found; well-differentiated disease, when glands similar 
to topical endometrium were found; undifferentiated disease, when the 
appearance of the glands was different from topical endometrium; and 
mixed disease, when the appearance of the glands was atypical or undif-
ferentiated.14 Endometriosis was staged according to the revised Ameri-
can Fertility Society (r-AFS) classification.15
Serum CA125 level 
Blood samples were collected on the first three days of the cycle pri-
or to surgery. After collection, the blood samples were immediately cen-
trifuged; the serum was removed, placed in a cryotube and frozen at -80 
°C. Serum CA125 levels were measured in accordance with the man-
ufacturer’s instructions (BYK-Sangtec Diagnostica GmbH, Germany). 
When the CA125 values were higher than 35 U/ml, a second measure-
ment was performed to confirm the result.
Figure 1. Photomicrographs at 100 X (A) and 400 X (B and C) of histological findings from peritoneum of asymptomatic fertile patients showing 
endometriosis (A and B), compared with normal tissue (C) (hematoxylin-eosin staining).
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Statistical analysis
The Mann-Whitney test was performed to compare the serum 
CA125 levels among the patients. The significance level was set at 5% 
(α ≤ 0.05). 
RESUlTS
The histopathological evaluation revealed that 13 (16.25%) out of 
these 80 patients (without any symptoms of endometriosis like infertil-
ity, dysmenorrhea and/or pelvic pain) showed level I or II endometriotic 
lesions. Of these patients, six (7.5%) had typical and four (5.0%) had 
atypical lesions. In three patients (3.8%), lesions were found only in the 
histopathological evaluation study (unapparent endometriosis). In six of 
these cases, the endometriosis was located in sacrouterine ligaments, and 
in five in ovarian fossae. In two cases, we found lesions at more than one 
site. No ovarian endometriosis was observed. 
No statistical difference in serum CA125 levels was observed be-
tween patients with and without endometriosis: means of 26.9 and 28.3 
U/ml, respectively (P = 0.6389 and sample power of 67%).
DISCUSSION
Endometriosis, a chronic painful inflammatory disease that is one 
of the most common gynecological disorders,7 is defined as the presence 
of a steroid hormone-dependent endometrium-like tissue consisting of 
glands and stroma that grows outside the uterine cavity. The target tis-
sues and organs include the fallopian tubes, ovaries, peritoneum, co-
lon, rectovaginal region and bladder.16 Endometriosis causes infertility, 
pelvic pain and dysmenorrhea.1,17 However, up to 20% of women may 
have endometriosis without presenting any symptoms.7 It is a polygen-
ic/multifactorial disease that includes not only hormonal and immuno-
logical factors, but also genetic factors.17
Considerable efforts have been made towards searching for nonin-
vasive diagnostic methods to detect endometriosis. Moreover, the use 
of biomarkers has been widely discussed. Abrão et al.8 evaluated serum 
CA125, C-reactive protein, amyloid A protein and anticardiolipin anti-
bodies during the menstrual phase and the middle follicular phase. They 
found that CA125 was the marker presenting the highest levels during 
the menstrual phase, between the first and third days of the cycle.
The high levels of CA125 in the bloodstream observed in the pres-
ence of an endometriotic ovarian cyst and/or endometriosis with deep 
infiltration suggest that this antigen may pass into the circulation from 
endometrial cells in patients with endometriosis.18,19 The CA125 re-
leased by the endometrium may reach the blood stream and lymphatic 
circulation via the peritoneal route, starting from retrograde menstrua-
tion, thereby allowing contact with local inflammatory reactions and 
thus releasing coelomic CA125.20 Another explanation for the increased 
levels of CA125 in the bloodstream could be its access into the abdomi-
nal cavity through tubal reflux, thus resulting in absorption by perito-
neal lymphatic vessels. Despite the mechanisms proposed, doubts still 
persist about the real mechanism of CA125 release into the circulation, 
considering that retrograde menstruation is still controversial and that 
the levels of this marker change during the postmenopausal period.20 
Koninckx and Martin21 evaluated CA125 and concluded that superfi-
cial endometriosis causes elevation of CA125 levels in peritoneal fluid, 
whereas the deep disease causes their elevation in blood.
Several hypotheses have been raised to explain the cause of elevat-
ed serum CA125 at the time of menstruation in patients with endo-
metriosis. They include higher membrane CA125 concentration in 
ectopic cells than in eutopic endometrial cells;22 bleeding relating to 
eutopic endometrium;23 increased transition of CA125 from endome-
trial tissue to peritoneum, relating to retrograde menses and eutopic 
endometrium;22,23 an enlarged surface area of endometrial tissue;24 in-
flammatory reaction due to the presence of endometriotic foci; and 
blood and endometrial shedding into the peritoneal cavity.23,24
Many studies have reported that serum CA125 levels were higher 
in patients with endometriosis, especially in those at an advanced level, 
suggesting that monitoring of CA125 in peripheral blood might reflect 
its behavior in the abdominal environment.3,25
On the other hand, some authors consider superficial endometriosis 
to be a physiological and intermittent condition in women during their 
reproductive years, whereas its progression, characterized as deep infil-
trative endometriosis and/or endometrial ovarian cysts, is considered to 
be the true disease.9,13,19,26 Divergences persist regarding the natural his-
tory of endometriosis, its symptoms, extent, location and staging. The 
presence of pelvic pain, especially dysmenorrhea, plus infertility and 
dyspareunia, are the trio that characterizes the disease.9
In the present study, 16.25% of the patients had mild endometrio-
sis, and the serum CA125 levels showed no difference between fertile 
asymptomatic women with and without endometriosis, although the 
number of cases investigated was small. Moreover, endometriosis was 
observed in healthy peritoneum of fertile women,27 in the same way as 
reported by Nezhat et al.,28 Nisolle et al.29 and Balasch et al.30 among 
women with infertility and pelvic pain.
CONClUSION
In conclusion, the data suggest that incidental findings of minimal/
mild endometriosis may not be of clinical significance, and progression 
of the disease probably occurs as a result of immunological and genetic 
abnormalities.The serum CA125 levels in our study did not show any 
diagnostic significance for detecting the disease. 
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